search
Back to results

A Randomized Clinical Trial for Depressed Mothers at Primary Care Level (DMH)

Primary Purpose

Depression

Status
Completed
Phase
Not Applicable
Locations
Chile
Study Type
Interventional
Intervention
monitorized pharmacotherapy with antidepressants drugs (Fluoxetine)
Sponsored by
Fondo Nacional de Desarrollo Científico y Tecnológico, Chile
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Depression focused on measuring depression, primary care, pharmacotherapy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • depressed mothers with al least one child aged 6-16

Exclusion Criteria:

  • currently treatment for depression,psychosis,bipolar depression,alcohol or drug abuse, gravidity.

Sites / Locations

  • CORESAM Conchali

Arms of the Study

Arm 1

Arm Type

Active Comparator

Arm Label

control group

Arm Description

patients can receive pharmacotherapy and psychotherapy and specialized treatment

Outcomes

Primary Outcome Measures

depressive symptoms measured with the HDRS

Secondary Outcome Measures

quality of life measured with the SF-36

Full Information

First Posted
August 17, 2007
Last Updated
August 20, 2007
Sponsor
Fondo Nacional de Desarrollo Científico y Tecnológico, Chile
search

1. Study Identification

Unique Protocol Identification Number
NCT00519051
Brief Title
A Randomized Clinical Trial for Depressed Mothers at Primary Care Level
Acronym
DMH
Official Title
Efectividad de la Farmacoterapia Monitorizada en Pacientes Deprimidas de la atención Primaria de Salud y su repercusión Sobre la Salud Mental de Sus Hijos
Study Type
Interventional

2. Study Status

Record Verification Date
August 2007
Overall Recruitment Status
Completed
Study Start Date
March 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
December 2006 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Fondo Nacional de Desarrollo Científico y Tecnológico, Chile

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
A randomized clinical trial was carried out at primary care level in Santiago, Chile to compare a pharmacological intervention for depressed mothers controlled by phone from a central level (TM) and the usual treatment (TH) and its impact on children's mental health. Hypothesis: pharmacological intervention for depression controlled by phone from a central level will be more effective than usual care in depressed mothers.
Detailed Description
Aim:to compare a pharmacological intervention for depressed mothers controlled by phone from a central level (TM) and the usual treatment (TH) and its impact on children's mental health. Material and methods: A RCT wasw carried out at primary care clinics in Santiago.Sample:three hundred and forty five depressed women . One children of each mother was randomly selected. Women are randomly assigned to receive the usual therapy or a pharmacological intervention with periodical telephone contacts with medical collaboration personnel, to reinforce compliance with treatment and educate about the disease, for 6 months. Women were blindly evaluated at 3, 6 and 12 months with the Hamilton depression rating score (HDRS) and the SF-36 to assess depressive symptoms and quality of life, respectively; the Dyadic Adjustment Scale to assess marital adjustment. Child psychopathology was assessed with the Child Behavior Checklist (CBCL), the Brief Psychiatric Rating Scale for Children (BPRS-C), Screen for Child Anxiety Related Emotional Disorders(SCARED)and the Children's Depression Inventory.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression
Keywords
depression, primary care, pharmacotherapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
345 (Actual)

8. Arms, Groups, and Interventions

Arm Title
control group
Arm Type
Active Comparator
Arm Description
patients can receive pharmacotherapy and psychotherapy and specialized treatment
Intervention Type
Other
Intervention Name(s)
monitorized pharmacotherapy with antidepressants drugs (Fluoxetine)
Other Intervention Name(s)
usual care
Intervention Description
Fluoxetine oral,20-60 mg/day for 6 months with telephone monitorization
Primary Outcome Measure Information:
Title
depressive symptoms measured with the HDRS
Time Frame
at 3,6 and 12 months after randomization
Secondary Outcome Measure Information:
Title
quality of life measured with the SF-36
Time Frame
at 3,6 and 12 months after randomization

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: depressed mothers with al least one child aged 6-16 Exclusion Criteria: currently treatment for depression,psychosis,bipolar depression,alcohol or drug abuse, gravidity.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
rosemarie fritsch, MD
Organizational Affiliation
University of Chile
Official's Role
Principal Investigator
Facility Information:
Facility Name
CORESAM Conchali
City
Santiago
State/Province
Region Metropolitana
Country
Chile

12. IPD Sharing Statement

Citations:
PubMed Identifier
17657327
Citation
Fritsch R, Araya R, Solis J, Montt E, Pilowsky D, Rojas G. [A randomized trial of pharmacotherapy with telephone monitoring to improve treatment of depression in primary care in Santiago, Chile]. Rev Med Chil. 2007 May;135(5):587-95. Epub 2007 Jul 9. Spanish.
Results Reference
result

Learn more about this trial

A Randomized Clinical Trial for Depressed Mothers at Primary Care Level

We'll reach out to this number within 24 hrs